Corporate News 10-Nov-23
Biocon Biologics divests its non-crore branded formulations biz in India
Biocon Biologics, a subsidiary of Biocon has divested the businesses in relation to its non-core branded formulations in India, comprising, inter alia, of generic dermatology and nephrology small molecule formulations (BFI Non-Core Business) to Eris Lifesciences on a ‘slump sale' basis.
Previous News
Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
( Results - Announcements 09-Feb-24 07:41 )
Biocon Ltd spurts 0.78%, up for five straight sessions
( Hot Pursuit - 08-Nov-23 13:01 )
Biocon Biologics signs distribution agreement with Sandoz
( Corporate News - 22-Dec-23 19:57 )
Biocon Ltd up for third consecutive session
( Hot Pursuit - 01-Dec-23 13:05 )
Indices edge lower, Nifty near 18,300; breadth positive
( Market Commentary - Mid-Session 24-May-23 09:32 )
Biocon consolidated net profit rises 31.27% in the March 2023 quarter
( Results - Announcements 24-May-23 07:33 )
Biocon to declare Quarterly Result
( Corporate News - 24-Apr-23 11:48 )
Biocon's Malaysia facility gets OAI status from USFDA
( Hot Pursuit - 18-Oct-23 08:42 )
Biocon announces resignation of senior management
( Corporate News - 08-Feb-24 19:49 )
Biocon inks pact with Juno Pharma for commercialization of Liraglutide
( Hot Pursuit - 09-Oct-23 10:11 )
Biocon reschedules AGM date
( Corporate News - 02-Jul-22 11:06 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
